AllQuantitative Report
Argus•April 07, 2021
Argus•April 07, 2021COLL: Lowering target price to $24.00
Summary
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platfor
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- AMPH: What does Argus have to say about AMPH?Apr 24, 2024 •
AMPH
- ANIP: What does Argus have to say about ANIP?Apr 24, 2024 •
ANIP
- PCRX: What does Argus have to say about PCRX?Apr 24, 2024 •
PCRX
- IRWD: Raising target price to $9.00Apr 24, 2024 •
IRWD
- XNCR: Lowering target price to $19.00Apr 24, 2024 •
XNCR